Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Colorectal Neoplasms

Free Subscription Articles published in Lancet Retrieve available abstracts of 15 articles: HTML format

Single Articles

November 2025
1. RASSCHAERT G, Tejpar S
   The dawn of immunotherapy in mismatch repair proficient colorectal cancer.
   Lancet. 2025;406:2302-2304.
   PubMed    
   
   
   October 2025
2. HECHT JR, Park YS, Tabernero J, Lee MA, et al
   Zanzalintinib plus atezolizumab versus regorafenib in refractory colorectal cancer (STELLAR-303): a randomised, open-label, phase 3 trial.
   Lancet. 2025 Oct 20:S0140-6736(25)02025-2. doi: 10.1016/S0140-6736(25)02025.
   PubMed     Abstract available
   
   
   July 2025
3. GARVEY G, Baykeda TA, Jahan S
   Early-onset colorectal cancer among Indigenous populations.
   Lancet. 2025;406:331.
   PubMed    
   
   
   June 2025
4. RAO S, Samalin-Scalzi E, Evesque L, Ben Abdelghani M, et al
   Retifanlimab with carboplatin and paclitaxel for locally recurrent or metastatic squamous cell carcinoma of the anal canal (POD1UM-303/InterAACT-2): a global, phase 3 randomised controlled trial.
   Lancet. 2025;405:2144-2152.
   PubMed     Abstract available
   
   
   March 2025
5. THE LANCET
   Colorectal cancer screening: FIT for purpose?
   Lancet. 2025;405:1027.
   PubMed    
   
   
   
6. ROBB KA, Young B, Murphy MK, Duklas P, et al
   Behavioural interventions to increase uptake of FIT colorectal screening in Scotland (TEMPO): a nationwide, eight-arm, factorial, randomised controlled trial.
   Lancet. 2025;405:1081-1092.
   PubMed     Abstract available
   
   
   
7. CASTELLS A, Quintero E, Bujanda L, Castan-Cameo S, et al
   Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trial.
   Lancet. 2025 Mar 27:S0140-6736(25)00145-X. doi: 10.1016/S0140-6736(25)00145.
   PubMed     Abstract available
   
   
   
8. BRETTHAUER M, Kalager M
   First head-to-head trial of colonoscopy versus faecal testing for colorectal cancer screening.
   Lancet. 2025 Mar 27:S0140-6736(25)00288-0. doi: 10.1016/S0140-6736(25)00288.
   PubMed    
   
   
   January 2025
9. HALDAR SD, Kopetz S
   Dual checkpoint blockade for microsatellite instability-high colorectal cancer.
   Lancet. 2025 Jan 23:S0140-6736(25)00144-8. doi: 10.1016/S0140-6736(25)00144.
   PubMed    
   
   
   
10. ANDRE T, Elez E, Lenz HJ, Jensen LH, et al
    Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial.
    Lancet. 2025 Jan 23:S0140-6736(24)02848-4. doi: 10.1016/S0140-6736(24)02848.
    PubMed     Abstract available
    
    
    September 2024
11. ADAM R, Piedvache C, Chiche L, Adam JP, et al
    Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial.
    Lancet. 2024;404:1107-1118.
    PubMed     Abstract available
    
    
    
12. HEINEMANN V, Stintzing S
    Liver transplantation in metastatic colorectal cancer: a new standard of care?
    Lancet. 2024;404:1078-1079.
    PubMed    
    
    
    July 2024
13. HOSTEN K, Kazi SI, Kardos A
    Takotsubo cardiomyopathy in a patient with Lynch syndrome.
    Lancet. 2024;404:276.
    PubMed    
    
    
    June 2024
14. ENG C, Yoshino T, Ruiz-Garcia E, Mostafa N, et al
    Colorectal cancer.
    Lancet. 2024 Jun 20:S0140-6736(24)00360-X. doi: 10.1016/S0140-6736(24)00360.
    PubMed     Abstract available
    
    
    May 2024
15. EDERHY S, Demondion P, Ali A, Montravers F, et al
    A right atrial mass and colonic cancer in a patient with Lynch syndrome.
    Lancet. 2024;403:e32.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge.